Financials

  • Market Capitalization 54.23 B
  • Employee 1 863
  • Founded 2008
  • CEO N/A
  • Website www.argenx.com
  • Headquarter Netherlands
  • FIGI BBG00GHB88X9
  • Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente

Related tickers

#NamePreis24h %7d %1M %1J %MarktkapitalisierungLetzte 7 Tage
125
VRTX
Vertex Pharmaceuticals Incorporated - Common Stock
480.25 USD-1.06%-9.39%+7.94%+1.53%121.89 B USD
238
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
663.09 USD-0.22%-0.01%+8.11%+15.81%69.52 B USD
378
RVMD
Revolution Medicines, Inc. - Common Stock
183.95 USD-1.57%-3.13%+18.68%+232.04%39.11 B USD
386
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
288.06 USD-3.58%-8.97%+1.82%-9.10%38.46 B USD

Nachrichten